Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
July 22, 2024 3:02 PM 2 min read

What's Going On With Canopy Growth Stock?

by Erica Kollmann Benzinga Staff Writer
Follow
CGC Logo
CGCCanopy Growth Corp
$1.187.80%
Overview

The Details:

Optimism is growing among cannabis investors following a series of political developments in the United States. Mostly recently, President Joe Biden suspended his campaign and endorsed Vice President Kamala Harris as the Democratic Presidential candidate on Sunday. 

Read Next: Serve Robotics Stock Rises After Nvidia Discloses 10% Stake

Canopy Growth shares also rose last week following the selection of Sen. J.D. Vance (R-Ohio) as Donald Trump's Vice-Presidential running-mate. 

According to a Marijuana Moment report, Vance believes states should set their own cannabis laws. He's also suggested that he’s against incarcerating individuals for low-level possession.

According to data from Benzinga Pro, Canopy Growth shares are trading about even with the stock’s 50-day moving average of $7.81, and the company will report its first-quarter results in early August. 

Should I Sell My CGC Stock?

When deciding to hold on to or sell a stock, investors should consider their time horizon, unrealized gains and total return.

Shares of Canopy Growth have increased by 99.01% in the past year. An investor who bought shares of Canopy Growth at the beginning of the year would make a profit of $3.07 per share if they sold it today. The stock has risen 12.37% over the past month, meaning an investor who bought shares on June 1 would see a capital loss of $0.16.

Investors may also consider market dynamics. The Relative Strength Index can be used to indicate whether a stock is overbought or oversold. Canopy Growth stock currently has an RSI of 69.09, indicating neutral conditions.

For access to advanced charting and analysis tools and stock data, check out Benzinga PRO. Try it for free.

CGC Price Action: According to Benzinga Pro, Canopy Growth shares are up 11.1% at $7.92 at the time of publication Monday.

Read Also:

  • What’s Going On With Rivian Stock?

Image: Pixabay

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
CannabisNewsMoversKamala HarrisPresident Joe Bidenwhy it's moving

Canopy Growth Corporation (NASDAQ:CGC) shares are trading higher Monday. Cannabis stocks have gained recently as optimism regarding potential federal policy changes grows.  Investors also assess Biden’s announcement that he will exit the 2024 presidential race.

Investors may be encouraged by the prospect of a Kamala Harris Presidential candidacy as she has been an outspoken proponent of the decriminalization of marijuana. Harris called the current classification of marijuana under federal law "absurd" during a White House event in March and said she is looking forward to seeing the Drug Enforcement Administration’s decision about moving it to a different category. 

CGC Logo
CGCCanopy Growth Corp
$1.187.80%
Overview
Comments
Loading...